Product Highlight - Evenity

Active ingredient: Romosozumab solution for injection 105 mg/ 1.17 mL (90 mg/mL) in prefilled syringes
Presentation: Solution for injection (prefilled syringe) 105 mg/ 1.17 mL (clear to opalescent, colorless to light yellow solution) x 2’s.
Indication: EVENITY is indicated for the treatment of osteoporosis in postmenopausal women at high risk for fracture, defined as a history of osteoporotic fracture, or multiple risk factors for fracture; or patients who have failed or are intolerant to other available osteoporosis therapy.